Tianjin pharmaceutical company emphasizes medical wearables
Tianjin Chase Sun Pharmaceutical Co Ltd, a high-tech medicine and health industry group, has extended its lines of business from manufacturing traditional Chinese medicines to making wearable medical equipment.
These devices, such as pulse oximeters, sleep monitors and blood pressure monitors, are designed for family use. Wu Fen, president of the company, said that future focus will be on further developing medical wearables.
Established in 1996, the company's sales revenue reached 4.5 billion yuan ($680 million) in 2015. As of the beginning of this year, it had total assets valued at 6.4 billion yuan and a market value of 15 billion yuan, with more than 5,400 employees. Sales revenue is expected to reach 5 billion yuan in 2016, up from 260 million yuan in 2009, according to Wu.